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The bacteria harbored by fungus-growing ants produce a variety
of small molecules that help maintain a complex multilateral symbi-
osis. In a survey of antifungal compounds from these bacteria, we
discovered selvamicin, an unusual antifungal polyene macrolide, in
bacterial isolates from two neighboring ant nests. Selvamicin resem-
bles the clinically important antifungals nystatin A1 and amphotericin
B, but it has several distinctive structural features: a noncationic
6-deoxymannose sugar at the canonical glycosylation site and a
second sugar, an unusual 4-O-methyldigitoxose, at the opposite end
of selvamicin’s shortened polyene macrolide. It also lacks some of
the pharmacokinetic liabilities of the clinical agents and appears to
have a different target. Whole genome sequencing revealed the pu-
tative type I polyketide gene cluster responsible for selvamicin’s bio-
synthesis including a subcluster of genes consistent with selvamicin’s
4-O-methyldigitoxose sugar. Although the selvamicin biosynthetic
cluster is virtually identical in both bacterial producers, in one it is on
the chromosome, in the other it is on a plasmid. These alternative
genomic contexts illustrate the biosynthetic gene cluster mobility
that underlies the diversity and distribution of chemical defenses
by the specialized bacteria in this multilateral symbiosis.
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Fungus-growing ants range from central Argentina to New YorkState, and in tropical regions they are the dominant herbivores.
The complex web of interactions involving these ants, their fungal
crops, specialized pathogens, and symbiotic bacteria has become
both a model system for chemical ecology and a productive source
of naturally occurring small molecules (1–4).
Fungus-growing ants collect plant material to feed their fungal
crop, which metabolizes the plant matter to provide nutrients for
the ants. Pathogenic ascomycetous fungi, especially members
of the genus Escovopsis, threaten the fungal crop. In response,
the ants maintain antibiotic-producing Actinobacteria (genus
Pseudonocardia) to provide chemical defenses (5). These bac-
teria produce antifungal and/or antibacterial agents, including
representatives of both nonribosomal peptide synthetase and
polyketide synthase (PKS) biosynthetic pathways (6–9).
As part of a systematic study of Pseudonocardia isolates derived
from the basal fungus-growing ant genus Apterostigma, we discovered
an unusual antifungal polyene, which we have named selvamicin
(Fig. 1). Selvamicin was found in two bacterial isolates from nearby
ant nests. Selvamicin shares features with the clinically important
antifungal agents amphotericin B and nystatin A1, both of which are
on the World Health Organization’s List of Essential Medicines (10),
and with the food preservative and topical antifungal natamycin (Fig.
1). Amphotericin B and nystatin A1 have serious liabilities in-
cluding high toxicity and negligible oral bioavailability, and their
continued use reflects the lack of better alternatives (11, 12).
Several features distinguish selvamicin from nystatin A1 and
amphotericin B: a second sugar, a truncated macrocyclic core,
and missing carboxylate and ammonium groups. The biosynthetic
gene cluster for selvamicin, which includes a subcluster of bio-
synthetic genes for the distinctive second sugar, was identified
bioinformatically. Whole genome sequencing revealed that in one
isolate the cluster resides on the chromosome while in the other it
resides on a plasmid. These divergent genomic contexts highlight
the gene cluster mobility that introduces and disseminates molec-
ular diversity in this system.
Results and Discussion
Discovery and Structure Elucidation.We examined two Pseudonocardia
isolates from ants in the genus Apterostigma collected at La Selva
Biological Station, Costa Rica, HH130629-09 and HH130630-07
(hereafter LS1 and LS2, respectively). We evaluated antifungal
activity of organic-soluble extracts of both cultured strains against
the common human fungal pathogen Candida albicans. The LS1
extract was active and we used activity-guided fractionation through
a C18 cartridge followed by reverse-phase HPLC to trace this activity
to a molecule with a previously unreported molecular formula of
C47H76O18 [high-resolution electrospray ionization mass spectrom-
etry (HR-ESI-MS) [M+Na]+ calcd 951.4924, expt 951.4928]. We
examined the LS2 extract by high-resolution liquid chromatography–
mass spectrometry (LC-MS) and observed the same compound,
although at approximately fivefold lower abundance. The active
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compound’s UV-vis spectrum is characteristic of a polyene, with
three prominent peaks (319, 334, 352 nm) consistent with a chro-
mophore of five conjugated double bonds (SI Appendix, Fig. S1).
Subsequent NMR analysis using a variety of 2D methods (COSY,
TOCSY, HMBC, H2BC, and ROESY) revealed this compound
to be an unreported polyene macrolide, which we have named
selvamicin after the site of our original collection.
Selvamicin production can be greatly up-regulated by adding high
concentrations of sodium butyrate (150 mM) to the culture medium
(SI Appendix, Fig. S7), consistent with reports that butyrate can
regulate secondary metabolism (13). We observed 13C labeling of
selvamicin when [1-13C] sodium butyrate was used, indicating that
butyrate can also act as a metabolic precursor, and similar results
were obtained with [1-13C] propionate (SI Appendix, Fig. S8).
COSY and TOCSY correlations allowed us to construct two
major fragments of the selvamicin macrolide: one from C2–C8
and another from C13 across the pentaene to the molecule’s
terminus at C31 (overlap of the polyene resonances prevented
definitive assignments of C19–C24, Fig. 2). HMBC couplings
link the C2–C8 fragment to quaternary carbons at either end: an
ester carbonyl at C1 (172.7 ppm) and a hemiketal at C9 (97.3 ppm).
The hemiketal forms a six-membered ring established by a series of
HMBC couplings from the hemiketal OH at C9, a tertiary alcohol
and methyl substituent at C12, and the other bridgehead carbon
at C13. H2BC correlations support the placement of substituents
along the macrolide core of selvamicin (SI Appendix, Fig. S2). A
series of ROESY correlations establishes an extended geometry
for the C2–C8 aliphatic chain and a chair conformation for the
hemiketal ring (SI Appendix, Fig. S2). These correlations, corrob-
orated by available scalar coupling constants, allowed the assign-
ment of relative stereochemistry from C4 to C13.
Our NMR analysis also revealed two sugars in the structure of
selvamicin. COSY and HMBC couplings revealed their planar
structures as 6-deoxy and 2,6-dideoxy hexoses, as shown in Fig. 2.
To better resolve the crowded sugar CH signals and reveal ad-
ditional peak fine structure, we reacted selvamicin with acetic
anhydride to modify its free hydroxyl groups. In the acetylation
product, the hemiketal at C9 was instead observed as a ketone,
and with the exception of the tertiary alcohol at C12, all OH
groups were acetylated (SI Appendix, Fig. S3). Scalar couplings
and ROESY correlations allowed the acetylated sugars in this
product to be assigned as (Ac)3-β-6-deoxymannose and Ac-α-4-
O-methyldigitoxose (SI Appendix, Fig. S4). The absolute con-
figurations of the sugars were not determined.
A clear HMBC coupling from the anomeric proton of the β-6-
deoxymannose places this sugar at C15 of selvamicin (Fig. 2).
Whereas no HMBC couplings were observed for the anomeric
proton of 4-O-methyldigitoxose, a series of ROESY correlations
(1′′-H/27-H, 1′′-H/33-H, 5′′-H/34′′-H) locates this sugar on the
opposite side of the macrolide at C27. The 1H and 13C chemical
shifts of the CH at position 27 support an oxygen substituent
linking this sugar. From C25–C31, we observed broadened 1H and
13C resonances, which obscured the couplings needed to establish
relative stereochemistry in this region. This peak broadening could
reflect conformational flexibility near the 4-O-methyldigitoxose
attachment.
Selvamicin’s structure diverges from the antifungal polyenes
amphotericin B, nystatin A1, and natamycin in several key re-
spects. Its 30-membered polyene macrolide core is intermediate
between that of the smaller antifungal natamycin and those of
amphotericin B and nystatin A1. Selvamicin’s unusual glycosylation
is also noteworthy. The 6-deoxymannose replaces the mycosamine
sugar common to most antifungal polyenes, and a second glyco-
sylation, observed here at C27, is also unusual.
Although uncommon, several diglycosylated antifungal poly-
enes have been reported in the literature, some derived from
Pseudonocardia. A diglycosylated nystatin analog named NPP was
isolated from Pseudonocardia autotrophica, although the addi-
tional sugar, an N-acetylglucosamine, is appended to the 4′ po-
sition of the mycosamine (14). A yet-unidentified nystatin analog
from the ant-associated Pseudonocardia strain P1 also appears to
have an additional sugar appendage at this same 4′ position (15).
Fig. 1. Structures of selvamicin and antifungal polyene natural products
currently in clinical use.
Fig. 2. Key NMR correlations establishing the planar structure of selvamicin.














A second glycosylation located instead on the opposite end of the
macrolide, as in selvamicin, has been observed among the minor
fermentation products of the nystatin A1 producer Streptomyces
noursei (nystatin A3, Fig. 1, and NYST1070), and the candidin
producer Streptomyces viridoflavus (candidoin), with the second
sugar located at C35, the position corresponding to selvamicin’s
4-O-methyldigitoxose attachment (16–18). Whereas structurally dis-
tinct from 4-O-methyldigitoxose, these are also 2,6-dideoxy sugars
(digitoxose, mycarose, and 2,6-dideoxy-L-erythro-hexopyranos-3-ulose,
respectively). Notably, in contrast to fermentations of S. noursei and
S. viridoflavus, we observe the diglycosylated polyene selvamicin as
the major polyene species, and neither monoglycosylated analog is
detectable by LC-MS in extracts of LS1 or LS2.
The presence of 4-deoxymannose in place of mycosamine re-
presents the only example to our knowledge of a noncationic
sugar at that position in a glycosylated polyene natural product.
Correspondingly, the usual paired carboxylate substituent (C16
in nystatin and amphotericin B and C12 in natamycin) is absent in
selvamicin. Instead, C12 bears a methyl group and a tertiary alcohol.
Antifungal Activity and Solubility. Liquid broth-based activity testing
confirmed selvamicin’s antifungal activity against C. albicans
(minimum inhibitory concentration, MIC, = 23 μM), with similar
activity observed across a panel of fungi (Saccharomyces cerevisiae,
Aspergillus fumigatus, and Trichoderma harzianum, Fig. 3 and SI
Appendix, Table S3). No activity was detected against either
Gram-negative (Escherichia coli) or Gram-positive (Bacillus
subtilis, Micrococcus luteus) bacteria. We note that selvamicin
has more modest antifungal activity than clinically used anti-
fungal polyenes such as nystatin A1 (MIC = 1.0 μM against
C. albicans). However, its improved aqueous solubility (2.3 mM
compared with 0.3 mM for nystatin A1) addresses a major limi-
tation of clinically available antifungal polyenes. Selvamicin’s
improved solubility, despite its lack of charged carboxylate and
ammonium groups, is probably contributed by its second sugar
moiety. Indeed, glycosylation has been reported to improve
solubility dramatically in analogs of nystatin; NPP, a diglycosy-
lated analog bearing N-acetylglucosamine, has more than 300-fold
greater aqueous solubility than nystatin A1 (14).
The activity of known antifungal polyenes derives from inter-
actions with ergosterol, the primary sterol of fungal plasma
membranes. Such interactions can compromise membrane integrity
and inhibit the function of membrane proteins (19, 20). Recent
studies suggest that ergosterol sequestration into extracellular ag-
gregates may be the dominant mechanism of action (21, 22), al-
though several polyenes, including nystatin and amphotericin B, have
also long been known to permeabilize membranes by the formation
of ergosterol-dependent transmembrane channels (23). The pre-
sumed geometry of these channels situates the charged end of the
molecule at the lipid–water interface, with the polyene and polyol
interacting with ergosterol within the plasma membrane. The dra-
matically different electrostatic nature of selvamicin would likely
preclude channel formation, with a hydrophilic yet uncharged sugar
at each end of the molecule. We probed for an interaction with er-
gosterol using an established isothermal calorimetry assay for binding
to liposome-embedded ergosterol (21, 24). These experiments
showed no evidence for binding, in stark contrast to control experi-
ments using nystatin A1, suggesting that this interaction is much at-
tenuated if present at all (SI Appendix, Fig. S9). Further investigation
of selvamicin’s mechanism of action is currently underway.
Biosynthetic Gene Cluster. To understand the genetic origins of
selvamicin biosynthesis, we turned to the genomes of Pseudo-
nocardia isolates LS1 (7) and LS2, which were sequenced using
PacBio technology (25, 26). We readily identified a large type I
PKS gene cluster in both genomes that matches the biosynthetic
requirements for selvamicin (Fig. 4). The 109-kbp selvamicin
biosynthetic gene clusters (BGC) from each isolate share perfect
synteny and 98.4% nucleotide identity over their length. In con-
trast, the whole genomes differ more substantially. The average
nucleotide identity (27) calculated across conserved replicons on
both chromosomes is only 83% and a comparison of housekeeping
gene sequences places LS1 and LS2 into distinct clades previously
established for ant-associated Pseudonocardia (28, 29). Overall,
the two BGCs are much more similar to one another than are
their bacterial hosts.
Surprisingly, the selvamicin BGC is situated in completely
different genomic contexts in the two selvamicin producers; in
LS1 it resides on the 6.1 Mbp circular chromosome, whereas in
LS2 it is on a 376-kbp plasmid, pLS2-1 (Fig. 4A). The presence of
an identical BGC in two divergent Pseudonocardia isolates, and
in different genomic contexts, points to horizontal transfer. In
keeping with BGC transfer, numerous mobile genetic elements
including transposases and integrases flank it in both genomes
(Fig. 4B). Mobile genetic elements are prominent features of
both genomes. On the pLS2-1 plasmid containing the selvamicin
BGC, an impressive 24% of all RAST-annotated genes are mobile
genetic elements.
Selvamicin provides the most striking example yet for the
emerging theme that plasmids drive the genetic, chemical, and
functional diversity found in Pseudonocardia symbionts. Plasmid-
derived BGCs for an antibacterial rebeccamycin analog and for
the gerumycin depsipeptides feature in other ant-associated
Pseudonocardia (7, 8). A rearranged variant of the gerumycin BGC
also appears on the LS1 chromosome, suggesting that plasmid-
mediated exchange also links the two gerumycin BGCs (7), but
at greater evolutionary distance than for the virtually identical
selvamicin BGCs.
Biosynthesis. The bioinformatically identified selvamicin cluster
resembles known type I PKS-derived polyene BGCs (30–35), and
a side-by-side comparison with the well-characterized nystatin
BGC (36, 37) readily reveals the origins of selvamicin’s unusual
structural features (Fig. 5). Both natural products derive from
type I iterative PKSs with polyketide elongation modules spread
across five genes (sel/nysB, -C, -I, -J, and -K). Relative to the
corresponding genes for nystatin, selC and selJ each lack two PKS
modules, corresponding to the observed four-carbon truncations
of selvamicin’s polyene and polyol moieties opposite one another
Fig. 3. Growth inhibition of C. albicans, S. cerevisiae, T. harzianum, and
A. fumigatus by selvamicin.
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on the macrolide. The polyketide backbone of selvamicin can be
traced through 14 PKS modules with ketoreductase (KR),
dehydratase (DH), and enoylreductase (ER) domains dictating
the oxidation state of each malonyl or methylmalonyl unit (SI
Appendix, Figs. S10 and S11). As often observed in type I PKS
modules, there are several presumably inactive vestigial domains
with mutations and/or truncations at their active sites: a DH and
ER in module 13 and a KR in module 11.
SelA, the putative PKS loading module for selvamicin’s pro-
pionate starter unit, shares several unusual features with known
polyene loading modules (36). Unlike most type I PKS loading
modules, SelA is a separate protein distinct from the first elon-
gation module and a serine is found in place of the canonical KS
active site cysteine. Like NysA, the nystatin loading module
critical for initiation of that molecule’s biosynthesis,17 SelA
contains a presumably inactive DH domain with no obvious
function. Atypically for type I PKS loading modules, the SelA
AT domain lacks the critical active site histidine and has a
large truncation of ∼65 amino acids in the middle of the domain
(SI Appendix, Fig. S10), suggesting that an alternative means of
loading the initial acyl starter unit may be operative.
Tailoring of the polyketide core of selvamicin requires hy-
droxylations at C4 and C12. SelL, a cytochrome p450 with ho-
mology to the p450 NysL that installs nystatin’s C10 hydroxyl, is
the most probable oxidase for C4 (38). We also identified SelP, a
2-oxoglutarate–dependent oxygenase with homology to phytanoyl-
CoA dioxygenases. No homologous enzyme has been observed in
other polyene clusters and this oxidase could be responsible for
selvamicin’s unusual C12 hydroxylation.
The canonical paired carboxylate and ammonium in antifungal
polyenes are both lacking in selvamicin. Notably, both the cy-
tochrome P450 NysN and ferredoxin NysM believed to install
nystatin’s carboxylate at C16 (37) are absent in the selvamicin
cluster, consistent with selvamicin’s unoxidized methyl substituent
at C12. The aminotransferase responsible for ammonium instal-
lation on the mycosamine sugar, NysDII, is also absent from
the selvamicin cluster. The remaining sugar-related enzymes in the
nystatin BGC, the mannose 4,6-dehydratase NysDIII and the
glycosyltransferase NysDI, both have homologs in the selvamicin
cluster and are consistent with the 6-deoxymannose found at C15.
The most significant divergence from nystatin’s BGC is a sub-
cluster of seven sugar biosynthesis genes, selSI through selSVII,
found in the middle of the selvamicin BGC. These include a
glycosyltransferase gene, selSV, and six genes consistent with
4-O-methyldigitoxose biosynthesis as a TDP-sugar from glucose-
1-phosphate (SI Appendix, Fig. S12) (39). The putative 4-O-
methyldigitoxose biosynthesis proteins are homologous to a similar
suite of proteins responsible for digitoxose biosynthesis in the
BGC for jadomycin B in Streptomyces venezuelae ISP5230 (40).
However, the selvamicin sugar subcluster contains an addi-
tional O-methyltransferase gene (selSI) and lacks an NDP-sugar
4-ketoreductase, which would normally be required for digitoxose
formation. Recently, 4-ketoreductase activity has been reported
for a bifunctional S-adenosylmethionine–dependent methyltransfer-
ase involved in the biosynthesis of mithramycin’s sugars (41–43).
Similar bifunctional activity could be operative for the SelSI methyl-
transferase or alternatively this activity could require a separate
4-ketoreductase outside the selvamicin BGC in both the LS1 and
LS2 genomes.
This sugar subcluster’s insertion within a cluster of familiar
polyene biosynthetic genes fits well with the paradigm of modular
subclusters recombining over the course of natural product evo-
lution to generate new products (44). Presumably, a similar suite
of genes synthesizes and attaches the digitoxose sugar to nystatin
A3, although no such subcluster occurs in the nystatin BGC from
Streptomyces noursei. Whole genome sequencing of this Streptomyces
strain may eventually reveal the location of these genes. We note
that nystatin A3 is a minor product of the nystatin BGC whereas
selvamicin is the principal product of the selvamicin cluster. The 4-O-
methyldigitoxose subcluster’s incorporation into the selvamicin BGC
likely reflects selection for diglycosylation in the principal product.
If this subcluster is truly modular, it presents an opportunity for
appending 4-O-methyldigitoxose to other polyene scaffolds to create
diglycoslated nystatin analogs, which are currently available only as
minor products from S. noursei fermentation but have comparable
anti-Candida potency to nystatin A1 (18). A solubility boost from
an additional sugar would address a major pharmacological limi-
tation of antifungals such as nystatin A1 and amphotericin B.
Fig. 4. (A) Genomes of Pseudonocardia isolates LS1 and LS2. The selvamicin BGC in each is marked with a red box. (B) Selvamicin BGCs from LS1 and LS2.
Mobile genetic element genes flanking the selvamicin clusters are shown as red arrows.















The systematic study of bacterially produced small molecules
from well-defined ecological niches continues to uncover poten-
tially useful molecules and to provide examples of the evolution of
molecular diversity. Selvamicin, a previously unknown antifungal
agent with activity against the human pathogen C. albicans, re-
presents a significant structural departure from the known anti-
fungal polyenes. Preliminary studies also indicate that selvamicin’s
atypical structure might be reflected in an unusual mechanism of
action. In other ant-associated Pseudonocardia we have reported
plasmid-encoded chemical defenses, and circumstantial evidence
for the integration of plasmid-encoded biosynthetic pathways into
chromosomes (7, 8). However, the variable genomic contexts for
selvamicin’s biosynthetic gene cluster—on a plasmid or on a
chromosome—provide the most convincing evidence to date for
horizontal gene transfer, illustrating an environment in which fre-
quently exchanged plasmids are the platforms for the formation
and transmission of a dynamic suite of chemical defenses.
Materials and Methods
Selvamicin Production and Purification. Spores of Pseudonocardia LS1 were
diluted into sterile double-distilled water and spread onto plates of ISP2
agar (BD Difco ISP2; 60 mL agar per 150 × 15 mm Petri dish) supplemented
with sodium butyrate (Aldrich, 150 mM final concentration, added after
autoclaving), which were incubated at 30 °C for 14 d. Agar was then cut into
squares and soaked in ethyl acetate overnight to extract organic compo-
nents from the solid media. This extract was decanted and the agar was
soaked in an additional volume of ethyl acetate for 3 h. The combined ethyl
acetate extracts were concentrated in vacuo and adsorbed onto celite for
dry packing onto a 10-g C18 SepPak column (Waters) that had been condi-
tioned with acetonitrile and preequilibrated with 30% acetonitrile in water.
Fractions were eluted with a step gradient of 30%, 50%, 70%, and 100%
acetonitrile in water and concentrated to dryness. Consecutive fractions from
elution at 50% acetonitrile were most active in inhibition of C. albicans.
Semipure material from these fractions was purified by reversed-phase HPLC
(Agilent 1200 series preparative HPLC equipped with a diode array detector;
Phenomenex Luna 10-μm phenyl-hexyl preparative column, 250 × 21.20 mm,
10 mL/min) with a gradient of 40–63% acetonitrile in water over 20 min.
Selvamicin eluted at 12.5 min. The overall yield of pure selvamicin (isolated
as an amorphous pale-yellow solid) was 50 mg/L of agar. Selvamicin: [α]D26 +128°
(MeOH); UV (MeOH) λmax (log e) 305 (4.4), 319 (4.7), 334 (4.9), 352 (4.9) nm; NMR
spectral data, see SI Appendix, Table S1; HR-ESI-MSm/z 951.4928 [M+Na]+ (calcd
for C47H76NaO18: 951.4924).
Determination of Minimum Inhibitory Concentration. Fresh DMSO solutions of
selvamicin and nystatin were prepared as serial dilutions and dispensed into
clear flat-bottom 96-well plates in 4 replicates. A starting inoculum of the
appropriate test strain in media was added to each well to yield a final
concentration of 1% DMSO by volume. The plates were incubated at 30 °C
with shaking at 200 rpm. Growth was assayed by OD600 readings taken on an
M5 plate reader (Molecular Devices). For E. coli, B. subtilis, andM. luteus, the
starting inoculum consisted of an overnight culture in LB diluted into LB
media at 10 μL/mL and final OD readings were taken at 22 h. For C. albicans
and S. cerevisiae, the starting inoculum consisted of an overnight culture in
yeast extract peptone dextrose (YPD) broth diluted to an OD600 of 0.05 in
YPD broth and final OD readings were taken at 14 h. For T. harzianum and
A. fumigatus, the starting inoculum consisted of a stock of concentrated
conidia diluted into potato dextrose broth at 2 μL/mL and final OD readings
were taken at 22 h. Using Prism (GraphPad), the OD data were normalized
and fit to a Gompertz function, from which MIC values were extracted as
described by Lambert and Pearson (45).
Genome Sequencing and Data Deposition. DNA isolation and genome se-
quencing was performed as described previously (7). The complete genome
for Pseudonocardia LS2 (HH130630-07) has been deposited in the GenBank
database (accession nos. CP013854, CP013855, and CP013856) and raw sequence
data have been deposited in the Sequence Read Archive (accession no.
SRP075179). The Pseudonocardia LS1 (HH130629-09) genome (7) can be
accessed using GenBank accession nos. CP011868 and CP011869.
Additional experimental details are available in the SI Appendix, including
preparation of Ac9-selvamicin, solubility determination, isothermal calorimetry
Fig. 5. Nystatin and selvamicin BGCs. Polyketide synthase genes are labeled with bold font. Coloring of the polyketide-derived portions of the nystatin A1
and selvamicin structures corresponds to the genes encoding their biosynthesis.
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sterol binding assay, induction with propionate and butyrate, and sequence
comparisons and analysis.
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